1231307-73-5

Basic information

• Product Name: 4-(3-chlorophenyl)-5-(methylthio)-3-phenyl-1H-pyrazole
• Synonyms: 4-(3-chlorophenyl)-5-(methylthio)-3-phenyl-1H-pyrazole
• CAS NO: 1231307-73-5
• Molecular Weight: 300.812
• Mol File: 1231307-73-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-(3-chlorophenyl)-5-(methylthio)-3-phenyl-1H-pyrazole(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-chlorophenyl)-5-(methylthio)-3-phenyl-1H-pyrazole(1231307-73-5)
• EPA Substance Registry System: 4-(3-chlorophenyl)-5-(methylthio)-3-phenyl-1H-pyrazole(1231307-73-5)

Safety Data

• Hazardous Substances Data: 1231307-73-5(Hazardous Substances Data)

Upstream product

• 75-15-0 carbon disulfide 
• 27798-43-2 2-(3-chlorophenyl)-1-phenylethanone 
• 74-88-4 methyl iodide 

Downstream Products

• 1231303-76-6 2-(((1s,4s)-4-((4-(3-chlorophenyl)-5-(methylthio)-3-phenyl-1H-pyrazol-1-yl)methyl)cyclohexyl)methoxy)acetic acid 

Relevant articles and documents

PYRAZOLYL SUBSTITUTED CARBONIC ACID DERIVATIVES AS MODULATORS OF THE PROSTACYCLIN(PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

Pyrazole derivatives of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of: pulmonary arterial hypertension (PAH) and related disorders; platelet aggregation; coronary artery disease; myocardial infarction; transient ischemic attack; angina; stroke; ischemia-reperfusion injury; restenosis; atrial fibrillation; blood clot formation in an angioplasty or coronary bypass surgery individual or in an individual suffering from atrial fibrillation; atherosclerosis; atherothrombosis; asthma or a symptom thereof; a diabetic-related disorder such as diabetic peripheral neuropathy, diabetic nephropathy or diabetic retinopathy; glaucoma or other disease of the eye with abnormal intraocular pressure; hypertension; inflammation; psoriasis; psoriatic arthritis; rheumatoid arthritis; Crohn's disease; transplant rejection; multiple sclerosis; systemic lupus erythematosus (SLE); ulcerative colitis; ischemia-reperfusion injury; restenosis; atherosclerosis; acne; type 1 diabetes; type 2 diabetes; sepsis; and chronic obstructive pulmonary disorder (COPD).